The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日Flu Hospitalization Rate Week 16, 2026?
Flu Hospitalization Rate Week 16, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$10,331 Vol.
$10,331 Vol.
2026/05/01
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$10,331 Vol.
$10,331 Vol.
2026/05/01
<80
$728 Vol.
No
80–85
$2,893 Vol.
No
85–90
$3,655 Vol.
Yes
90–95
$1,610 Vol.
No
95–100
$805 Vol.
No
100+
$640 Vol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
マーケット開始日： Apr 24, 2026, 11:18 AM ET
音量
$10,331終了日
2026/05/01マーケット開始日
Apr 24, 2026, 11:18 AM ETResolver
0x69c47De9D...提案された結果: No
異議申し立てなし
最終結果: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
音量
$10,331終了日
2026/05/01マーケット開始日
Apr 24, 2026, 11:18 AM ETResolver
0x69c47De9D...提案された結果: No
異議申し立てなし
最終結果: No
The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問